Project Summary

Tailoring treatments to individual patients (precision medicine) has the potential to greatly improve patient outcomes. Oftentimes there are tradeoffs between more and less aggressive treatments. There is a need for new statistical methods that can be used to learn about what strategies work best from existing clinical data sets.

This study will evaluate the development of new machine learning methods that can inform how often to monitor clinical markers of disease and how to alter patients’ treatment based on these markers. The research will also create novel methods to interrogate causal mechanisms in the context of adaptive treatment and monitoring strategies as potential targets for further optimization. In addition, evidence will be generated to inform the ideal chemotherapy roadmaps and echocardiographic monitoring schedules for patients treated for pediatric acute myeloid leukemia (AML).

An advisory panel of key stakeholders including patients, physicians, clinical researchers, and methodologists will be formed, who will inform the design and conduct of each aim of the proposed research, as well as the dissemination of the methodological advances. The multidisciplinary membership of the advisory panel will ensure the methods developed have broad applicability and straightforward implementation. The study team will specifically engage the Children’s Hospital of Philadelphia Family Advisory Council, COG Patient Advocacy Committee, patients treated for childhood AML, and pediatric oncologists and cardiologists to be sure their perspectives on the risk tradeoffs related to chemotherapy and monitoring for associated cardiotoxicity are reflected in the design of the applied research.

Project Information

Jason Roy, PhD, MS
Rutgers University School of Public Health

Key Dates

July 2022
January 2027


Award Type
Health Conditions Health Conditions These are the broad terms we use to categorize our funded research studies; specific diseases or conditions are included within the appropriate larger category. Note: not all of our funded projects focus on a single disease or condition; some touch on multiple diseases or conditions, research methods, or broader health system interventions. Such projects won’t be listed by a primary disease/condition and so won’t appear if you use this filter tool to find them. View Glossary
State State The state where the project originates, or where the primary institution or organization is located. View Glossary
Last updated: January 20, 2023